🚀 Oligonucleotides for CNS Summit Europe 🌍

Join us for a groundbreaking event as Europe's oligonucleotide sector embarks on a transformative growth journey! With the impressive €21 million launch of Aerska and significant collaborations with major players like Novartis, SciNeuron, Lundbeck, and Contera, the biopharma landscape is rapidly evolving to tackle previously undruggable CNS diseases.

The inaugural Oligonucleotides for CNS Summit Europe will bring together 60+ senior industry leaders for the first-ever European forum solely focused on CNS-targeted oligonucleotide therapeutics. Over three days, participants will engage in highly technical, data-driven discussions that delve into the unique challenges of CNS development. Key topics will include:

• 🚧 Overcoming hurdles in CNS therapeutics
• 📦 Innovative BBB delivery strategies beyond TfR1
• 🧬 Enhanced in vivo and iPSC models
• ✨ Novel chemistry and conjugation methodologies
• 🔄 Translational strategies that ensure successful transition from preclinical to clinical and regulatory environments.

This is your opportunity to connect and collaborate with thought leaders in the field, as we shape the future of RNA-based CNS innovation together!

🗓️ Event Details:

• Dates: 10 oktober 17:00 - 19:00

🎟️ Tickets:

• Conference + Pre-Conference Workshop Day + Breakfast Briefing - Drug Developer: EUR 3946.00
• Conference + Pre-Conference Workshop Day - Drug Developer: EUR 3397.00
• Conference Only - Drug Developer: EUR 2499.00
• Conference + Pre-Conference Workshop Day + Breakfast Briefing - Academic: EUR 3246.00
• Conference + Pre-Conference Workshop Day - Academic: EUR 2797.00
• Conference Only - Academic: EUR 2099.00
• Conference + Pre-Conference Workshop Day - Solution Provider: EUR 4797.00
• Conference Only - Solution Provider: EUR 3499.00

🎤 Featured Speakers:

• Farzaneh Salem - GSK
• Michal Lubas - Lundbeck
• Felix Schumacher - Roche
• Helene Tran - Servier
• Duygu Yilmaz - Aerska
• Macarena Hernandez - AptaTargets
• Beatriz Llamusi Troisi - Arthex Biotech
• Chris Shaw - AviadoBio
• Soren Rasmussen - Contera Pharma
• Guillaumje Hautbergue - Crucible Therapeutics
• Jan Thirkettle - Harness Therapeutics
• Gerard Platenburg - ProQR Therapeutics
• Miriam Bujny - Sapreme Technologies
• Irene Tur - Secarna Pharmaceuticals
• Piotr Putaj - Vico Therapeutics
• Poul Sørensen - Inverna Therapeutics

Let's come together to catalyze the future of CNS treatments! 🎉